A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

Background: This phase II trial (Cancer and Leukemia Group B 90102) sought to determine the efficacy of cisplatin, standard infusion of gemcitabine and gefitinib in patients with advanced urothelial carcinoma. Patients and methods: Eligible patients had previously untreated measurable disease, Easte...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Philips, G. K., Halabi, S., Sanford, B. L., Bajorin, D., Small, E. J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2009
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2685451/
https://ncbi.nlm.nih.gov/pubmed/19168670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn749
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi